TCL Archive NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act September 20, 1974
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI January 18, 1991
TCL Archive Deep Budget Cuts Poised to Kick in March 1; Hill Insiders See Little Hope for Deal February 15, 2013
